# Linde plc (LIN) · Edgar & Edgarette company card

> Linde (LIN) grew revenue 3.0% in FY2025 to $34.0 billion, operating margin 26.3% against a 3.0% median for industrial inorganic chemicals, equity 44.1% of assets, and dividend per share up 9 years running. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1707925 · fiscal year ended 2025-12-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/LIN) · [JSON](https://www.pops4.com/boards/company/LIN.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $34.0B |
| Revenue growth, 1 year | 3.0% |
| Revenue growth per year | 2.5% |
| Operating margin | 26.3% (prior year 26.2%) |
| Net margin | 20.8% |
| Operating cash flow | $10.3B |
| Capital spending | $5.3B |
| Free cash flow | $5.1B |
| Cash | $5.1B |
| Long-term debt | $22.5B |
| Total assets | $86.8B |
| Total equity | $38.2B |
| Equity ÷ assets | 44.1% |
| Return on equity | 18.5% |
| Dividend per share | $6 |
| Dividend years rising | 9 |

## Readings, computed from those figures

- Altman Z: 2.03 (grey zone)
- Piotroski F: 4 of 9 (middling)
- Health Harbor boat: New ship · no warning signs
- Cash Compass: Cash cow now · steady, with strong cash arriving today

## Edgarette's reading

Exposure: revenue $34.0B (FY2025), total debt $22.5B. Experience: revenue up 3.0% on the year, up 2.5% a year over 4 years; operating margin 26.3%, up from 26.2%. Soundness: equity 44.1% of assets, return on equity 18.5%, payout 39.8% of profit, dividend per share up 9 years running. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $31.0B and $36.1B next year (method v4.1: its own 4-year record of growth weighed at 50% against $10B+ filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $29.0B to $38.3B. A statistical range, not company guidance. Against peers (9 filers, $50M+ revenue, industrial inorganic chemicals): operating margin 26.3% against a 3.0% median; growth 3.0% against -1.3%.

Range logged 2026-09-26, receipt 8d910c5eb292eb8e, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

No warning filings in the window.

## Recent filings

- 10-Q · filed 2026-10-29 · [filing](https://www.sec.gov/Archives/edgar/data/1707925/000162828026068079/0001628280-26-068079-index.htm)
- 8-K · filed 2026-10-29 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1707925/000165495426009199/0001654954-26-009199-index.htm)
- 10-Q · filed 2026-07-31 · [filing](https://www.sec.gov/Archives/edgar/data/1707925/000162828026051289/0001628280-26-051289-index.htm)
- 8-K · filed 2026-07-31 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1707925/000165495426007052/0001654954-26-007052-index.htm)
- 8-K · filed 2026-07-30 · 5.07 Submission of Matters to a Vote of Security Holders; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1707925/000119312526325127/0001193125-26-325127-index.htm)
- 8-K · filed 2026-05-13 · 8.01 Other Events; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1707925/000119312526221558/0001193125-26-221558-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001707925.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1707925

## Cite

POPS4, Edgar & Edgarette: Linde plc (LIN) company card, from the company's own SEC filings, accessed 2026-11-10, https://www.pops4.com/boards/company/LIN. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.